Lisa Bodei, MD, PhD
Memorial Sloan Kettering Cancer Center
4
4
1
N/A
0
3
Research Impact
N/A
Research impact score
0
Total publications
0
Published trial results
0
Total citations
Drug Portfolio
Analytics
Trial Phases
Trial Status
Role Distribution
Activity Timeline
Clinical Trials (4)
Research Network
Collaboration Network
Research Areas & Affiliations
Therapeutic Areas
Affiliations
Similar Key Opinion Leaders
Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.
Jonathan Strosberg, M.D.
H. Lee Moffitt Cancer Center and Research Institute
Shared therapeutic areas:
Naris Nilubol, M.D.
National Cancer Institute (NCI)
Shared therapeutic areas:
Jaydira Del Rivero, M.D.
National Cancer Institute (NCI)
Shared therapeutic areas:
George Albert Fisher M.D. Ph.D.
Stanford University
Shared therapeutic areas:
Francois Benard, MD
BC Cancer
Shared therapeutic areas:
Bassel El-Rayes, MD
Emory University Winship Cancer Institute
Shared therapeutic areas:
Steven A Rosenberg, M.D.
National Cancer Institute (NCI)
Shared therapeutic areas:
Neeta Pandit-Taskar, MD
Memorial Sloan Kettering Cancer Center
Shared therapeutic areas:
Worked with same sponsors:
Stanislaw R. Burzynski, MD, PhD
Burzynski Research Institute
Shared therapeutic areas:
Brennan Spiegel, MD, MSHS
Cedars-Sinai Medical Center
Shared therapeutic areas:
Publications (0)
No publications found for this investigator.
Clinical Trials (4)
Showing 4 of 4 trials
Defining Response Criteria for PET Scans for People With Neuroendocrine Tumors
177Lu-DOTA-EB-TATE in Adult Patients With Advanced, Well- Differentiated Neuroendocrine Tumors
Lutathera in People With Gastroenteropancreatic (GEP), Bronchial or Unknown Primary Neuroendocrine Tumors That Have Spread to the Liver
A Study of 177Lu-DTPA-SC16.56 in People With Neuroendocrine Carcinomas of the Lung and Prostate
All 4 trials loaded